— Know what they know.
Not Investment Advice
Also trades as: NVV1.F (FSX) · $vol 0M

NVAX NASDAQ

Novavax, Inc.
1W: -4.0% 1M: +6.3% 3M: -2.4% YTD: +25.9% 1Y: +16.9% 3Y: +17.5% 5Y: -93.2%
$9.21
+0.23 (+2.56%)
 
Weekly Expected Move ±10.7%
$7 $8 $9 $10 $11
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 59 · $1.5B mcap · 141M float · 3.36% daily turnover · Short 45% of daily vol

📊 Key Metrics

TTM
$596M
Revenue
-52.5% YoY
$-88M
Net Income
-118.3% YoY
$-97M
Free Cash Flow
+51.0% YoY
78.0%
Gross Margin
-11.1%
Op. Margin
-6.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE23.4%
ROA-6.4%
ROIC8.6%

Valuation

P/E-17.1
P/B-10.4
EV/EBITDA-14.8

Leverage

Debt/Equity-1.95
Current Ratio2.13
Interest Cov.-6.4x

Quality Scores

Piotroski F2/9
Altman Z-4.00
Beneish M0.07

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms